Acute motor response following a single IVIG treatment course In chronic inflammatory pemyelinating polyneuropathy

Muscle and Nerve

Volumn 39, Issue 4, 2009, Pages 439-447

  Harb, Thomas ^a   Andersen, Henning ^a   Jakobsen, Johannes ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Intravenous immunoglobulin; Muscle strength; Treatment response

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CASE STUDY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DYNAMOMETRY; ELECTROPHYSIOLOGY; FEMALE; FUNCTION TEST; HAND FUNCTION; HUMAN; LATENT PERIOD; MALE; MOTOR PERFORMANCE; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SENSATION; SENSORY NERVE CONDUCTION; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; WALKING SPEED;

ADULT; AGED; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; ISOTONIC CONTRACTION; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE STRENGTH; MUSCLE STRENGTH DYNAMOMETER; NEURAL CONDUCTION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PROSPECTIVE STUDIES; QUALITY OF LIFE; SENSORY RECEPTOR CELLS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65649089462     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21305     Document Type: Article

References (35)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force, Neurology 199l;41:617-618.
2. Andersen H, Jakobsen J. A comparative study of isokinetic dynamometry and manual muscle testing of ankle dorsal and plantar flexors and knee extensors and flexors. Eur Neurol 1997;37:239-242. (Pubitemid 27212033)
3. Andersen H, Stalberg E, Falck B. F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve 1997:20:1296-1302. (Pubitemid 27415518)
4. Barohn RJ, Kissel JT. Warmolts JR, Mendell JR. Chronic in-flammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-884. (Pubitemid 19199372)
5. Bjoemer J, Damsgaard M, Watt T, Becb B, Rasmussen N, Kristensen T, et al. The Danish SF-36 Manual. Lif Laegemid-delindustriforeningen; 2007.
6. Cutter GR, Baier ML. Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999: 122 (Pt5) :871-882. (Pubitemid 29219261)
7. Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther 2004: 102:177-193. (Pubitemid 38887692)
8. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997:49:229-239. (Pubitemid 27328707)
9. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-637.
10. Dyck PJ, Litchy WJ, Kratz KM, Suarez GA, Low PA, Pineda AA. et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory7 demyelinating polyradiculoneuropathy. Ann Neurol 1994;36:838-845. (Pubitemid 24370922)
11. Dyck PJ, O'Brien PC, Kosanke JL, Gillen DA, Karnes JL. A 4. 2. and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology 1993;43:1508-1512.
12. Falck B, Stålberg E, Bitsch A. Sensory nerve conduction studies with surface electrodes. Methods Clin Neurophysiol 1994; 5:1-20.
13. Flansbjer UB, Downham D, Lexell J. Knee muscle strength, gait performance, and perceived participation after stroke. Arch Phys Med Rehabil 2006;87:974-980.
14. Fraser JL, Olney RK. The relative diagnostic sensitivity of different F-wave parameters in various polyneuropathies. Muscle Nerve 1992:15:912-918.
15. Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatoiy demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 1996;119 (Pt 4) :1067-1077. (Pubitemid 26300709)
16. Hughes R, Bensa S, Willison H, Van den BP, Comi G, Illa I, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201. (Pubitemid 32738144)
17. Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatoiy demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-332. (Pubitemid 43344970)
18. Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, et al. Intravenous immune globulin (10% caprylate-chro-matography purified) for the treatment of chronic inflammatoiy demyelinating polyradiculoneuropathy (ICE study) : a randomised placebo-controlled trial. Lancet Neurol 2008;7: 136-144.
19. Kohara N, Kimura J, Kaji R, Goto Y, Ishii J, Takiguchi M, et al. F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia 2000;43:915-921. (Pubitemid 30463172)
20. Roller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005: 352:1343-1356. (Pubitemid 36605061)
21. McCrone P. Chisholm D, Knapp M. Hughes R, Comi G. Dalakas MC, et al. Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatoiy demyelinating polyradiculoneuropathy. Eur J Neurol 2003;10: 687-694. (Pubitemid 38030879)
22. Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Na-garaja HN, et al. Randomized controlled trial of IVIg in untreated chronic inflammatoiy demyelinating polyradiculoneuropathy. Neurology 2001;56:445-449. (Pubitemid 32172866)
23. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doom PA. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neu-rosurg Psychiatry 2002;72:596-601. (Pubitemid 34462813)
24. Merkies IS, Schmitz PI, ran der Meche FG, van Doom PA. Comparison between impairment and disability scales in immune-mediated polyneuropathies. Muscle Nerve 2003;28:93-100. (Pubitemid 36775965)
25. Noreau L, Vachon J. Comparison of three methods to assess muscular strength in individuals with spinal cord injury. Spinal Cord 1998;36:716-723. (Pubitemid 28479077)
26. Stålberg E, Falck B. Clinical motor nerve conduction studies. Methods Clin Neurophysiol 1993;4:61-80.
27. Thompson N, Choudhary P, Hughes RA, Quinlivan RM. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1996;243:280-285. (Pubitemid 26071992)
28. van Doom PA. Brand A. Strengers PF, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 1990;40:209-212. (Pubitemid 20099423)
29. van Doorn PA. Dippel, DWJ, Vermeulen. M. Longterm IV immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2007;12 (S1) :89 (Abstract).
30. van Doom PA, Vermeulen M, Brand A, Mulder PG, Busch HF. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratoiy characteristics associated with improvement. Arch Neurol 1991;48:217-220.
31. Vermeulen M, van der Meche FG, Speelman JD, Weber A, Busch HF. Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy, J Neurol Sci 1985;70:317-326. (Pubitemid 15242351)
32. Vermeulen M, van Doom PA, Brand A, Strengers PF, Jennek-ens FG, Busch HF. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993;56:36-39. (Pubitemid 23062977)
33. Vucic S, Black K, Baldassari LE, Tick Chong PS, Dawson KT, Cros D. Long-term effects of intravenous immunoglobulin in CIDP. Clin Neurophysiol 2007;118:1980-1984 (Pubitemid 47193192)
34. Ware JF. Jr. The status of health assessment 1994. Annu Rev-Public Health 1995;16:327-354.
35. Willen C, Sunnerhagen KS, Ekman C, Grimby G. How is walking speed related to muscle strength? A study of healthy persons and persons with late effects of polio. Arch Phys Med Rehabil 2004;85:1923-1928. (Pubitemid 39593516)